doi:10.1016/S0969-8051(03)00028-3 page 7
http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
Prescription and OTC Drug Product List 8/1998 Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 8: August 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE TABLET; ORAL TABLET; ORAL - ADD - BUTALBITAL, ACETAMINOPHEN AND CAFFEINE MODURETIC 5-50 - ADD - AB MALLINCKRODT...
Prescription and OTC Drug Product List 1/1998 IRRIGANT AEROSOL, METERED; INHALATION - DLT - AT GLAXO WELLCOME EQ 40MG BASE/ML; ATROVENT - DLT - 200,000 UNITS/ML N60707 001 - DLT - BOEHRINGER INGELHEIM 0.018MG/INH N19085 001 - ADD - AT MONARCH PHARMS EQ 40MG BASE/ML; - DLT - DEC 29, 1986 - ADD - 200,000 UNITS/ML N60707 001 - ADD - + 0.018MG/INH N19085 001 - ADD - DEC 29, 1986 PERMETHRIN ISOSULFAN BLUE CREAM; TOPICAL ELIMITE...
1996 and Older - New Drug Application (NDA) New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information OfficeKit for the Preparation of Technetium Tc 99m Disofenin Merck 18467/ S...
Prescription and Over-the-Counter Drug Product List: 3/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
Prescription and OTC Drug Product List 8/1999 RTU IN PLASTIC CONTAINER - DLT - MAR 19, 1999 - ADD - AP + BAXTER HLTHCARE 500MG/100ML N18657 001 - DLT - AP + SCS 500MG/100ML N18657 001 LORACARBEF MINOCYCLINE HYDROCHLORIDE CAPSULE; ORAL LORABID CAPSULE; ORAL - ADD - KING PHARMS 200MG N50668 001 - DLT - MINOCYCLINE HCL - ADD - DEC 31, 1991 - DLT - AB WARNER CHILCOTT EQ 50MG BASE N63066 001 - ADD - + 400MG N50668 002 - DLT - AUG 14,...
August Drug Approvals Original Application #: 020508 Approval Date: 29-AUG-96 Trade Name: LAC-HYDRIN Chemical Type: 3 Therapeutic Potential: S Dosage Form: CREAM Applicant: BRISTOL MYERS CO Active Ingredient(s): AMMONIUM LACTATE OTC/RX Status: RX Indication(s): ICHTHYOSIS VULGARIS AND XEROSIS Original Application #: 020532 Approval Date: 26-AUG-96 Trade Name: IVY BLOCK Chemical Type: 1 Therapeutic...
http://www.fda.gov/cder/da/ddpa93.wpd 74 207 NAPROXEN COPLEY NAPROXEN 02 26 93 (TABLET) CANTON, MA 250MG 02021 375MG 500MG (NONSTEROIDAL ANTI INFLAMMATORY) 19 715 DIPENTUM KABI OLSALAZINE SODIUM 01 05 93 (CAPSULE) PISCATAWAY, NJ 250MG 08855 (REVISED LABELING CLINICAL PHARMACOLOGY; PRECAUTIONS; ADVERSE REACTIONS) 09 218 COUMADIN DUPONT WARFARIN SODIUM 02 01 93 (TABLET) WILMINGTON, DE 1MG 19880 2MG 2.5MG 5MG 7.5MG 10MG ...
chrmscat.p65 page 1
author: cxm9300
LIST OF APPROVED DRUGS FOR WHICH ADDITIONAL PEDIATRIC INFORMATION Medical Imaging And Radiopharmaceutical Drug Products Technetium Tc -99m Apcitide Scintigraphic imaging of acute venous thrombosis in the lower extremities in patients who have signs and symptoms of acute venous thrombosisTechnetium Tc -99m Disofenin Hepatobiliary imaging agent
Prescription and OTC Drug Product List 7/2001 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE -A- AB ABLE 325MG;50MG;40MG N40390 001 JUL 23, 2001 JUL NEWA -A- AB 500MG;50MG;40MG N40394 001 JUL 23, 2001 JUL NEWA ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -D- AA + WATSON LABS 325MG;7.5MG...
may20lst.PDF 98N- 0056 May 20, 1998 Page 11 Drug Name Potential pediatric use limited to approved indications Age Group In Which More Information Needed birth to 1 mos 1 mos to 2 yrs 2 to 12 years 12 to 16 years Technetium Tc - 99m Mebrofenin Radioactive diagnostic for hepatobiliary imaging Yes Yes Yes Yes Technetium Tc - 99m Medronate Bone imaging agent to...
author: Unknown
may20lst.PDF page 11
author: Unknown
http://www.draxis.com/pdf/fact_sheet.pdf It markets radioactive products sold as ready- to- use sterile parenterals, and non- radioactive lyophilized kits intended for use with Technetium - 99m
Draxis Form 20-F for FYE 1201 as Filed SEDAR.DOC page 23
author: ChrisO
http://www.freseniushc.com/product/April_1_2001_Update.pdf April 1 2001 Update Addendum A. Update of Calendar Year 2001 Hospital Outpatient Payment Rates and Coinsurance Amounts Effective April 1, 2001 National Minimum Status Relative Payment Unadjusted Unadjusted APC Group Title Indicator Weight Rate Coinsurance Coinsurance 0001 Photochemotherapy ...
http://www.freseniushc.com/product/April_1_2001_Update.pdf page 8 April 1 2001 Update 1024 Quinupristin 150 mg/ dalfopriston 350 J $102.05 $13.67 $13.67 1045 I- 131 MIBG (ioben- sulfate) O. 5mCi G $1,140.00 $139.08 $139.08 1059 Carticel, auto cult- chndr cyte G $14,250.00 $2,010.00 $2,010.00 1079 CO 57/ 58 0.5 mCi G $264.10 $32.22 $32.22 1084 Denileukin diftitox, ...
Palatin Technologies - The Leader in Melanocortin-based Therapeutics To address this issue, Tyco International today brought together a broad panel of medical and economic experts to outline the problem and describe how a breakthrough imaging agent, NeutroSpec(TM) [Technetium (99m Tc) fanolesomab], can help reduce the human pain and economic cost of misdiagnosed appendicitis.technetium -labeled anti-CD...
Palatin Technologies - The Leader in Melanocortin-based Therapeutics (Amex: PTN - News) today announced that they have extended their marketing agreement for Palatin's infection imaging agent, NeutroSpec(TM) (Technetium Tc -99m fanolesomab), to include exclusive marketing and distribution rights in Europe.
Palatin Technologies - The Leader in Melanocortin-based Therapeutics Rapid diagnosis of pedal osteomyelitis in diabetics with a Technetium -99m -labeled monoclonal antigranulocyte antibody.Tc -99m anti-CD 15 neutrophil monoclonal antibody (NeutroSpec®) scan for diagnosis of equivocal appendicitis: Clinical evaluation of safety, efficacy and patient management.99m Tc -labeled IgM...
PII: S0969-8051(01)00218-9 page 5
PII: S0969-8051(01)00218-9 page 4
doi:10.1016/S0969-8051(03)00028-3 page 2
http://www.neoprobe.com/UCSD/ASOwallace2003.pdf page 8
